# FMCQF (Fresenius Medical Care AG) - SEC EDGAR Financial Statements

> Fresenius Medical Care AG reported €19.63B in revenue and net income of €978.4M for the fiscal year ended December 31, 2025 (up 1.5% year over year), with a 25.6% gross margin and a 9.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/FMCQF
- Markdown: https://convexityos.com/fundamentals/FMCQF.md
- SEC CIK: 0001333141
- Reporting currency: EUR
- Latest filing period: December 31, 2025
- Last synced: Nov 20, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001333141&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | €19.63B | +1.5% YoY |
| Operating Income | FY 2025 | €1.83B | 9.3% margin |
| Net Income | FY 2025 | €978.4M | 5.0% net margin |
| Diluted EPS | FY 2025 | €3.36 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | €1.60B | Total debt: €10.80B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | €19.63B | €19.34B | €19.45B | €19.40B | €17.62B | €17.86B | €17.48B | €16.55B | €17.78B | €16.57B |
| Cost of Revenue | €14.60B | €14.58B | €14.53B | €14.50B | €12.85B | €12.32B | €12.08B | €11.39B | €11.77B | €10.95B |
| **Gross Profit** | €5.03B | €4.76B | €4.93B | €5.31B | €5.08B | €5.54B | €5.40B | €5.15B | €6.02B | €5.62B |
| Research & Development | €158.0M | €183.5M | €232.0M | €228.6M | €220.8M | €193.8M | €168.0M | €114.1M | €111.0M | €146.5M |
| Selling, General & Admin | €3.03B | €3.14B | €3.20B | €3.17B | €2.77B | €3.13B | €3.03B | €2.89B | €3.64B | €3.13B |
| **Operating Income** | €1.83B | €1.39B | €1.37B | €1.51B | €1.85B | €2.30B | €2.27B | €3.04B | €2.36B | €2.41B |
| **EBITDA** | €3.29B | €2.93B | €2.98B | €3.23B | €3.44B | €3.89B | €3.82B | €3.76B | €3.10B | €3.11B |
| Interest Income | €69.61M | €71.58M | €88.22M | €67.66M | €73.17M | €41.96M | €61.62M | €147.4M | €51.38M | -€63.40M |
| Interest Expense | €375.2M | €393.3M | €420.9M | €359.0M | €343.8M | €407.1M | €486.0M | €438.0M | -€364.8M | -€363.4M |
| Income Before Tax | €1.51B | €1.06B | €1.03B | €1.22B | €1.57B | €1.94B | €1.84B | €2.74B | €2.00B | €2.05B |
| Income Tax Expense | €321.0M | €316.1M | €300.6M | €325.0M | €352.8M | €500.6M | €401.6M | €511.1M | €443.1M | €625.4M |
| **Net Income** | €978.4M | €537.9M | €499.0M | €673.4M | €969.3M | €1.16B | €1.20B | €1.98B | €1.28B | €1.14B |
| Basic EPS | €3.36 | €1.83 | €1.70 | €2.30 | €3.31 | €3.96 | €3.96 | €6.47 | €4.17 | €3.74 |
| **Diluted EPS** | €3.36 | €1.83 | €1.70 | €2.30 | €3.31 | €3.96 | €3.96 | €6.45 | €4.16 | €3.73 |
| Basic Shares Outstanding | 291.2M | 293.4M | 293.4M | 293.2M | 292.9M | 294.1M | 302.7M | 306.5M | 306.6M | 305.75B |
| Diluted Shares Outstanding | 291.2M | 293.4M | 293.4M | 293.2M | 292.9M | 294.1M | 302.7M | 306.5M | 306.6M | 305.75B |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | €1.60B | €1.18B | €1.40B | €1.27B | €1.48B | €1.08B | €1.01B | €2.15B | €978.1M | €708.9M |
| **Cash & Short-Term Investments** | €1.60B | €1.18B | €1.40B | €1.27B | €1.48B | €1.08B | €1.01B | €2.15B | €978.1M | €708.9M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | €3.42B | €3.23B | -- | -- |
| Inventory | €2.14B | €2.07B | €2.18B | €2.30B | €2.04B | €1.90B | €1.66B | €1.47B | €1.29B | €1.34B |
| Other Current Assets | €533.4M | €671.8M | €730.5M | €919.1M | €876.2M | €1.05B | €913.6M | €804.1M | €604.5M | €1.14B |
| **Total Current Assets** | €7.90B | €7.92B | €8.70B | €8.20B | €7.97B | €7.28B | €7.17B | €7.85B | €6.37B | €6.88B |
| Property, Plant & Equipment, Net | €3.49B | €3.65B | €3.78B | €4.15B | €4.24B | €4.06B | €4.19B | €3.84B | €3.49B | €3.58B |
| Goodwill | €13.57B | €15.17B | €14.65B | €15.79B | €14.36B | €12.96B | €14.02B | €12.21B | €12.10B | €12.96B |
| Intangible Assets | €1.25B | €1.37B | €1.36B | €1.52B | €1.46B | €1.38B | €1.43B | €681.3M | €683.1M | €803.1M |
| Long-Term Investments | €663.7M | €620.8M | €642.9M | €773.7M | €786.9M | €761.1M | €696.9M | €649.8M | €647.0M | €598.2M |
| Other Non-Current Assets | €218.2M | €198.3M | €223.6M | €814.6M | €924.6M | €775.0M | €752.5M | €673.0M | €410.0M | €391.7M |
| **Total Non-Current Assets** | €23.10B | €25.64B | €25.23B | €27.55B | €26.40B | €24.41B | €25.77B | €18.40B | €17.65B | €18.62B |
| **Total Assets** | €31.00B | €33.57B | €33.93B | €35.75B | €34.37B | €31.69B | €32.93B | €26.24B | €24.03B | €25.50B |
| Accounts Payable | -- | -- | -- | -- | -- | -- | €716.5M | €641.3M | €590.5M | €575.6M |
| Short-Term Debt | €1.60B | €577.4M | €944.6M | €1.34B | €1.92B | €1.09B | €2.62B | €2.31B | €1.64B | €1.30B |
| Deferred Revenue (Current) | €97.95M | €66.73M | €56.57M | €63.27M | €428.0M | €571.4M | €22.80M | €37.63M | €0 | -- |
| Other Current Liabilities | €1.04B | €1.05B | €1.19B | €2.98B | €3.33B | €3.19B | €2.49B | €2.38B | €2.36B | €2.46B |
| **Total Current Liabilities** | €6.25B | €5.66B | €6.11B | €6.47B | €7.26B | €6.06B | €7.06B | €6.27B | €5.30B | €5.30B |
| Long-Term Debt | €5.69B | €6.26B | €6.96B | €7.17B | €6.65B | €6.80B | €6.46B | €5.05B | €5.79B | €6.83B |
| Other Non-Current Liabilities | €147.6M | €177.6M | €157.5M | €988.4M | €524.3M | €836.0M | €508.1M | €622.3M | €821.8M | €917.4M |
| **Total Non-Current Liabilities** | €10.47B | €12.14B | €12.99B | €13.84B | €13.13B | €13.30B | €12.65B | €7.07B | €7.90B | €9.15B |
| **Total Liabilities** | €16.72B | €17.80B | €19.10B | €20.30B | €20.39B | €19.36B | €19.71B | €13.34B | €13.20B | €14.45B |
| **Total Debt (incl. Leases)** | €10.80B | €10.99B | €12.19B | €13.19B | €13.32B | €12.38B | €18.36B | €7.55B | €6.68B | €7.56B |
| Common Stock | €293.4M | €293.4M | €293.4M | €293.4M | €293.0M | €292.9M | €304.4M | €307.9M | €308.1M | €307.2M |
| Retained Earnings | €12.21B | €11.27B | €10.92B | €10.71B | €10.83B | €10.25B | €9.45B | €8.83B | €7.14B | €6.09B |
| **Total Stockholders' Equity** | €13.31B | €14.58B | €13.62B | €13.99B | €12.70B | €11.22B | €11.96B | €11.76B | €9.82B | €9.98B |
| Total Equity | €14.28B | €15.77B | €14.83B | €15.45B | €13.98B | €12.33B | €13.23B | €12.90B | €10.83B | €11.05B |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | €1.60B | €1.18B | €1.40B | €1.27B | €1.48B | €1.08B | €1.01B | €2.15B |
| **Cash & Short-Term Investments** | €1.60B | €1.18B | €1.40B | €1.27B | €1.48B | €1.08B | €1.01B | €2.15B |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | €3.42B | €3.23B |
| Inventory | €2.14B | €2.07B | €2.18B | €2.30B | €2.04B | €1.90B | €1.66B | €1.47B |
| Other Current Assets | €533.4M | €671.8M | €730.5M | €919.1M | €876.2M | €1.05B | €913.6M | €804.1M |
| **Total Current Assets** | €7.90B | €7.92B | €8.70B | €8.20B | €7.97B | €7.28B | €7.17B | €7.85B |
| Property, Plant & Equipment, Net | €3.49B | €3.65B | €3.78B | €4.15B | €4.24B | €4.06B | €4.19B | €3.84B |
| Goodwill | €13.57B | €15.17B | €14.65B | €15.79B | €14.36B | €12.96B | €14.02B | €12.21B |
| Intangible Assets | €1.25B | €1.37B | €1.36B | €1.52B | €1.46B | €1.38B | €1.43B | €681.3M |
| Long-Term Investments | €663.7M | €620.8M | €642.9M | €773.7M | €786.9M | €761.1M | €696.9M | €649.8M |
| Other Non-Current Assets | €218.2M | €198.3M | €223.6M | €814.6M | €924.6M | €775.0M | €752.5M | €673.0M |
| **Total Non-Current Assets** | €23.10B | €25.64B | €25.23B | €27.55B | €26.40B | €24.41B | €25.77B | €18.40B |
| **Total Assets** | €31.00B | €33.57B | €33.93B | €35.75B | €34.37B | €31.69B | €32.93B | €26.24B |
| Accounts Payable | -- | -- | -- | -- | -- | -- | €716.5M | €641.3M |
| Short-Term Debt | €1.60B | €577.4M | €944.6M | €1.34B | €1.92B | €1.09B | €2.62B | €2.31B |
| Deferred Revenue (Current) | €97.95M | €66.73M | €56.57M | €63.27M | €428.0M | €571.4M | €22.80M | €37.63M |
| Other Current Liabilities | €1.04B | €1.05B | €1.19B | €2.98B | €3.33B | €3.19B | €2.49B | €2.38B |
| **Total Current Liabilities** | €6.25B | €5.66B | €6.11B | €6.47B | €7.26B | €6.06B | €7.06B | €6.27B |
| Long-Term Debt | €5.69B | €6.26B | €6.96B | €7.17B | €6.65B | €6.80B | €6.46B | €5.05B |
| Other Non-Current Liabilities | €147.6M | €177.6M | €157.5M | €988.4M | €524.3M | €836.0M | €508.1M | €622.3M |
| **Total Non-Current Liabilities** | €10.47B | €12.14B | €12.99B | €13.84B | €13.13B | €13.30B | €12.65B | €7.07B |
| **Total Liabilities** | €16.72B | €17.80B | €19.10B | €20.30B | €20.39B | €19.36B | €19.71B | €13.34B |
| **Total Debt (incl. Leases)** | €10.80B | €10.99B | €12.19B | €13.19B | €13.32B | €12.38B | €18.36B | €7.55B |
| Common Stock | €293.4M | €293.4M | €293.4M | €293.4M | €293.0M | €292.9M | €304.4M | €307.9M |
| Retained Earnings | €12.21B | €11.27B | €10.92B | €10.71B | €10.83B | €10.25B | €9.45B | €8.83B |
| **Total Stockholders' Equity** | €13.31B | €14.58B | €13.62B | €13.99B | €12.70B | €11.22B | €11.96B | €11.76B |
| Total Equity | €14.28B | €15.77B | €14.83B | €15.45B | €13.98B | €12.33B | €13.23B | €12.90B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | €1.19B | €740.9M | €732.5M | €894.3M | €1.22B | €1.44B | €1.44B | €2.23B | €1.55B | €1.42B |
| Depreciation & Amortization | €1.46B | €1.54B | €1.61B | €1.72B | €1.59B | €1.59B | €1.55B | €724.8M | €735.5M | €701.5M |
| Stock-Based Compensation | -- | -- | -- | -- | -- | -- | €1.99M | €10.74M | €46.81M | €27.43M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -€105.8M | -€164.7M | -€131.7M | -€246.9M |
| Change in Inventory | -€248.7M | €107.9M | -€13.14M | -€204.3M | -€48.53M | -€355.8M | -€117.5M | -€157.1M | -€62.69M | -€60.23M |
| **Operating Cash Flow** | €2.68B | €2.39B | €2.63B | €2.17B | €2.49B | €4.23B | €2.57B | €2.06B | €2.19B | €1.93B |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -€1.12B | -€1.06B | -€944.5M | €930.5M |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | €1.44B | €1.00B | €1.25B | €2.86B |
| Acquisitions, Net | -€15.30M | -€177K | -€3.14M | €10.53M | -€324.8M | -€214.8M | -€2.16B | -€250.0M | -€521.3M | -- |
| Purchases of Investments | -€87.52M | -€81.50M | -€102.4M | -€105.6M | -€129.1M | -€96.40M | -€11.31M | -€480.3M | -- | -- |
| Sales & Maturities of Investments | €83.50M | €75.13M | €89.59M | €57.67M | €144.5M | €42.24M | €16.62M | €150.2M | €256.1M | -- |
| **Investing Cash Flow** | -€722.5M | -€84.94M | -€544.2M | -€734.7M | -€1.20B | -€1.33B | -€3.29B | -€245.0M | -€991.5M | -€1.25B |
| Share Repurchases | -€585.3M | -- | -- | -- | -- | -€366.0M | -€599.8M | -€37.22M | -€57.94M | €0 |
| Dividends Paid | -- | -- | -- | -- | -- | -€351.2M | -€354.6M | -€324.8M | -€294.0M | €244.3M |
| **Financing Cash Flow** | -€1.40B | -€2.57B | -€1.86B | -€1.62B | -€1.02B | -€2.66B | -€466.6M | -€681.7M | -€798.6M | -€519.7M |
| **Net Change in Cash** | €413.8M | -€241.9M | €153.4M | -€207.9M | €400.1M | €73.82M | -€1.14B | €1.17B | €269.2M | €204.2M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 25.6% | 24.6% | 25.3% | 27.4% | 28.8% | 31.0% | 30.9% | 31.2% | 33.8% | 33.9% |
| **Operating Margin** | 9.3% | 7.2% | 7.0% | 7.8% | 10.5% | 12.9% | 13.0% | 18.4% | 13.3% | 14.5% |
| **Net Profit Margin** | 5.0% | 2.8% | 2.6% | 3.5% | 5.5% | 6.5% | 6.9% | 12.0% | 7.2% | 6.9% |
| Return on Equity (ROE) | 7.4% | 3.7% | 3.7% | 4.8% | 7.6% | 10.4% | 10.0% | 16.9% | 13.0% | 11.5% |
| Return on Assets (ROA) | 3.2% | 1.6% | 1.5% | 1.9% | 2.8% | 3.7% | 3.6% | 7.6% | 5.3% | 4.5% |
| Current Ratio | 1.26x | 1.40x | 1.42x | 1.27x | 1.10x | 1.20x | 1.02x | 1.25x | 1.20x | 1.30x |
| Quick Ratio | 0.92x | 1.03x | 1.07x | 0.91x | 0.82x | 0.89x | 0.78x | 1.02x | 0.96x | 1.05x |
| Debt to Equity | 0.81x | 0.75x | 0.89x | 0.94x | 1.05x | 1.10x | 1.54x | 0.64x | 0.68x | 0.76x |
| **Revenue Growth (YoY)** | +1.5% | -0.6% | +0.3% | +10.1% | -1.3% | +2.2% | +5.6% | -7.0% | +7.3% | +7.2% |
| Gross Profit Growth (YoY) | +5.7% | -3.4% | -7.3% | +4.6% | -8.3% | +2.6% | +4.7% | -14.3% | +7.2% | +8.5% |
| Operating Income Growth (YoY) | +31.2% | +1.7% | -9.4% | -18.4% | -19.6% | +1.5% | -25.3% | +28.6% | -1.9% | +13.2% |
| **Net Income Growth (YoY)** | +81.9% | +7.8% | -25.9% | -30.5% | -16.8% | -2.9% | -39.5% | +54.9% | +11.9% | +19.8% |
| EPS Growth (YoY) | +83.6% | +7.6% | -26.1% | -30.5% | -16.4% | 0.0% | -38.8% | +55.2% | +11.5% | +19.1% |
| Operating Cash Flow Growth (YoY) | +12.4% | -9.2% | +21.3% | -12.9% | -41.2% | +64.9% | +24.5% | -5.9% | +13.4% | +9.4% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | +43.6% | -19.5% | -56.4% | +215.4% |
| 5Y Revenue / Share Growth | +11.0% | +14.1% | +22.8% | +14.0% | +110878.0% | +19.6% | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | +32.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -15.1% | -53.7% | -73.7% | -45.0% | +88334.5% | +26.2% | -- | -- | -- | -- |
| 10Y Net Income / Share Growth | +7.1% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
